论文部分内容阅读
目的评价自体材料替代肺动脉在肺癌外科治疗中的价值。方法将104例肺血管受累的肺癌患者分为两组,自体材料替代肺动脉成形术组42例,常规肺动脉成形组62例。比较两组间术后并发症、肺功能状态以及生存率。结果两组在术后并发症、术后1年存活患者肺功能状态上无明显差异,而自体材料组术后1年生存率明显优于常规组,术后3年生存率两组无明显差异。结论自体材料替代肺动脉成形术临床疗效满意,值得推广应用。
Objective To evaluate the value of autologous material replacement pulmonary artery in the surgical treatment of lung cancer. Methods 104 cases of lung cancer patients with pulmonary vascular involvement were divided into two groups. Of the 42 patients who underwent pulmonary angioplasty with autologous material, 62 patients underwent routine pulmonary angioplasty. Postoperative complications, lung function status and survival rate were compared between the two groups. Results There was no significant difference in postoperative complications and lung function status of patients surviving one year after surgery, while the 1-year survival rate of self-material group was significantly better than that of conventional group. There was no significant difference in 3-year survival rate between the two groups . Conclusions Self-material replacement pulmonary angioplasty has satisfactory clinical effect and is worth popularizing.